{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:25:10Z","timestamp":1794507910712,"version":"4.9.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Human dihydroorotate dehydrogenase (DHODH) is the rate-limiting enzyme in pyrimidine de novo synthesis and represents a promising target for cancer therapy. However, current inhibitors of DHODH have limited clinical effectiveness and adverse effects. Herein, we report NK-A 17E-233I, a novel small-molecule inhibitor of the human DHODH enzyme, identified through a prospective virtual screening methodology. Molecular docking and biochemical assays show NK-A 17E-233I functions as a pure or partial competitive inhibitor with respect to the natural\u00a0substrate, dihydroorotate (DHO). It adopts a distinct binding mode from classical inhibitors that target the flavin mononucleotide (FMN) binding cavity of the hydrophobic tunnel. NK-A 17E-233I exhibits selective cytotoxicity in both human cancer cell lines and patient-derived intestinal organoids, inducing DNA damage, S-phase arrest, and cell death. Unlike Brequinar, NK-A 17E-233I preserves mitochondrial respiration via complexes I and II and maintains ATP-linked basal respiration, avoiding the impairment of the electron transport chain (ETC). Our findings imply the aptitude of NK-A 17E-233I as a novel competitive inhibitor of human DHODH, representing a significant advancement in this field since the 1990s.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s13046-025-03538-w","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:52:22Z","timestamp":1760705542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["NK-A 17E-233I: a novel competitive inhibitor of human dihydroorotate dehydrogenase (DHODH) for cancer therapy"],"prefix":"10.1186","volume":"44","author":[{"given":"Mohammed Moustapha","family":"Anwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Meseguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e9stor","family":"Garc\u00eda-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Krupinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9leste","family":"Sele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Rodr\u00edguez-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samna","family":"Sagadevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Ramon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Occhipinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Angione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Ord\u00f3\u00f1ez-Mor\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Knecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Huertas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Angeles","family":"Juanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"3538_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100125","author":"K Hodroj","year":"2021","unstructured":"Hodroj K, Barthelemy D, Lega J-C, Grenet G, Gagnieu M-C, Walter T, et al. Issues and limitations of available biomarkers for fluoropyrimidine-based chemotherapy toxicity, a narrative review of the literature. ESMO Open. 2021. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100125.","journal-title":"ESMO Open"},{"issue":"5","key":"3538_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","volume":"23","author":"NJ Mullen","year":"2023","unstructured":"Mullen NJ, Singh PK. Nucleotide metabolism: a pan-cancer metabolic dependency. Nat Rev Cancer. 2023;23(5):275\u201394. https:\/\/doi.org\/10.1038\/s41568-023-00557-7.","journal-title":"Nat Rev Cancer."},{"issue":"9","key":"3538_CR3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.molmed.2005.07.003","volume":"11","author":"M L\u00f6ffler","year":"2005","unstructured":"L\u00f6ffler M, Fairbanks LD, Zameitat E, Marinaki AM, Simmonds HA. Pyrimidine pathways in health and disease. Trends Mol Med. 2005;11(9):430\u20137. https:\/\/doi.org\/10.1016\/j.molmed.2005.07.003.","journal-title":"Trends Mol Med"},{"issue":"7","key":"3538_CR4","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1046\/j.1432-1327.2000.01213.x","volume":"267","author":"J Rawls","year":"2000","unstructured":"Rawls J, Knecht W, Diekert K, Lill R, L\u00f6ffler M. Requirements for the mitochondrial import and localization of dihydroorotate dehydrogenase. Eur J Biochem. 2000;267(7):2079\u201387. https:\/\/doi.org\/10.1046\/j.1432-1327.2000.01213.x.","journal-title":"Eur J Biochem"},{"issue":"1","key":"3538_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0969-2126(00)00077-0","volume":"8","author":"S Liu","year":"2000","unstructured":"Liu S, Neidhardt EA, Grossman TH, Ocain T, Clardy J. Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents. Structure. 2000;8(1):25\u201333. https:\/\/doi.org\/10.1016\/S0969-2126(00)00077-0.","journal-title":"Structure"},{"issue":"1","key":"3538_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1432-1033.1996.0292h.x","volume":"240","author":"W Knecht","year":"1996","unstructured":"Knecht W, Bergjohann U, Gonski S, Kirschbaum B, L\u00f3ffler M. Functional expression of a fragment of human dihydroorotate dehydrogenase by means of the baculovirus expression vector system, and kinetic investigation of the purified recombinant enzyme. Eur J Biochem. 1996;240(1):292\u2013301. https:\/\/doi.org\/10.1111\/j.1432-1033.1996.0292h.x.","journal-title":"Eur J Biochem"},{"issue":"1","key":"3538_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0009-2797(99)00144-1","volume":"124","author":"W Knecht","year":"2000","unstructured":"Knecht W, Henseling J, L\u00f6ffler M. Kinetics of inhibition of human and rat dihydroorotate dehydrogenase by atovaquone, lawsone derivatives, brequinar sodium and polyporic acid. Chem Biol Interact. 2000;124(1):61\u201376. https:\/\/doi.org\/10.1016\/S0009-2797(99)00144-1.","journal-title":"Chem Biol Interact"},{"issue":"1","key":"3538_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/oxfordjournals.annonc.a057680","volume":"1","author":"PF Dodion","year":"1990","unstructured":"Dodion PF, Wagener T, Stoter G, Drozd A, Lev LM, Skovsgaard T, et al. Phase II trial with Brequinar (DUP-785, NSC 368390) in patients with metastatic colorectal cancer: a study of the early clinical trials group of the EORTC. Ann Oncol. 1990;1(1):79\u201380. https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a057680.","journal-title":"Ann Oncol"},{"issue":"12","key":"3538_CR9","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1080\/15257770.2018.1508692","volume":"37","author":"GJ Peters","year":"2018","unstructured":"Peters GJ. Re-evaluation of brequinar sodium, a dihydroorotate dehydrogenase inhibitor. Nucleosides Nucleotides Nucleic Acids. 2018;37(12):666\u201378. https:\/\/doi.org\/10.1080\/15257770.2018.1508692.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"3538_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107398","volume":"93","author":"RD Alamri","year":"2021","unstructured":"Alamri RD, Elmeligy MA, Albalawi GA, Alquayr SM, Alsubhi SS, El-Ghaiesh SH. Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: a comprehensive review. Int Immunopharmacol. 2021;93:107398. https:\/\/doi.org\/10.1016\/j.intimp.2021.107398.","journal-title":"Int Immunopharmacol"},{"key":"3538_CR11","doi-asserted-by":"publisher","unstructured":"Franco ML, Garc\u00eda-Carpio I, Comaposada-Bar\u00f3 R, Escribano-Saiz JJ, Ch\u00e1vez-Guti\u00e9rrez L, Vilar M. TrkA-mediated endocytosis of p75-CTF prevents cholinergic neuron death upon \u03b3-secretase inhibition. Life Sci Alliance 2021;4(4):e202000844.\u00a0https:\/\/doi.org\/10.26508\/lsa.202000844","DOI":"10.26508\/lsa.202000844"},{"key":"3538_CR12","doi-asserted-by":"publisher","unstructured":"Mizutani T, Clevers H. Primary Intestinal Epithelial Organoid Culture BT-Intestinal Stem Cells: Methods and Protocols. In: Ord\u00f3\u00f1ez-Mor\u00e1n P, editor. New York, NY: Springer US; 2020. p. 185\u2013200. Available from: https:\/\/doi.org\/10.1007\/978-1-0716-0747-3_11","DOI":"10.1007\/978-1-0716-0747-3_11"},{"key":"3538_CR13","doi-asserted-by":"publisher","unstructured":"Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47(W1):W357\u201364. Available from: https:\/\/doi.org\/10.1093\/nar\/gkz382","DOI":"10.1093\/nar\/gkz382"},{"issue":"1","key":"3538_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3\u201325. 1. Adv Drug Deliv Rev. 2001;46(1):3\u201326. https:\/\/doi.org\/10.1016\/S0169-409X(00)00129-0.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"3538_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/open.201600015","volume":"5","author":"F Mao","year":"2016","unstructured":"Mao F, Kong Q, Ni W, Xu X, Ling D, Lu Z, et al. Melting point distribution analysis of globally approved and discontinued drugs: a research for improving the chance of success of drug design and discovery. ChemistryOpen. 2016;5(4):357\u201368. https:\/\/doi.org\/10.1002\/open.201600015.","journal-title":"ChemistryOpen"},{"issue":"11","key":"3538_CR16","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1021\/acs.jcim.4c00412","volume":"64","author":"J Wellnitz","year":"2024","unstructured":"Wellnitz J, Martin H-J, Anwar Hossain M, Rath M, Fox C, Popov KI, et al. Stoplight: a hit scoring calculator. J Chem Inf Model. 2024;64(11):4387\u201391. https:\/\/doi.org\/10.1021\/acs.jcim.4c00412.","journal-title":"J Chem Inf Model"},{"issue":"1","key":"3538_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717. https:\/\/doi.org\/10.1038\/srep42717.","journal-title":"Sci Rep"},{"issue":"10","key":"3538_CR18","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1038\/s41375-019-0461-5","volume":"33","author":"S Christian","year":"2019","unstructured":"Christian S, Merz C, Evans L, Gradl S, Seidel H, Friberg A, et al. The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies. Leukemia. 2019;33(10):2403\u201315. https:\/\/doi.org\/10.1038\/s41375-019-0461-5.","journal-title":"Leukemia"},{"issue":"1","key":"3538_CR19","doi-asserted-by":"publisher","first-page":"A3.B.1","DOI":"10.1002\/0471142735.ima03bs111","volume":"111","author":"W Strober","year":"2015","unstructured":"Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol. 2015;111(1):A3.B.1-A3.B.3. https:\/\/doi.org\/10.1002\/0471142735.ima03bs111.","journal-title":"Curr Protoc Immunol"},{"key":"3538_CR20","unstructured":"Liu Y, Lu Y, Yang C. Evaluating In Vitro DNA Damage Using Comet Assay. JoVE. 2017;(128):e56450. Available from: https:\/\/app.jove.com\/56450"},{"issue":"9","key":"3538_CR21","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1083\/jcb.201702007","volume":"216","author":"MA Juanes","year":"2017","unstructured":"Juanes MA, Bouguenina H, Eskin JA, Jaiswal R, Badache A, Goode BL. Adenomatous polyposis coli nucleates actin assembly to drive cell migration and microtubule-induced focal adhesion turnover. J Cell Biol. 2017;216(9):2859\u201375. https:\/\/doi.org\/10.1083\/jcb.201702007.","journal-title":"J Cell Biol"},{"key":"3538_CR22","doi-asserted-by":"publisher","unstructured":"Alnassar N, Hajto J, Rumney RMH, Verma S, Borczyk M, Saha C, et al. Ablation of the dystrophin Dp71f alternative C-terminal variant increases sarcoma tumour cell aggressiveness. Hum Mol Genet. 2024;ddae094. https:\/\/doi.org\/10.1093\/hmg\/ddae094","DOI":"10.1093\/hmg\/ddae094"},{"issue":"20","key":"3538_CR23","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1093\/bioinformatics\/btab324","volume":"37","author":"G Magazz\u00f9","year":"2021","unstructured":"Magazz\u00f9 G, Zampieri G, Angione C. Multimodal regularized linear models with flux balance analysis for mechanistic integration of omics data. Bioinformatics. 2021;37(20):3546\u201352. https:\/\/doi.org\/10.1093\/bioinformatics\/btab324.","journal-title":"Bioinformatics"},{"key":"3538_CR24","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1002\/1873-3468.14180","volume":"595","author":"E Yaneske","year":"2021","unstructured":"Yaneske E, Zampieri G, Bertoldi L, Benvenuto G, Angione C. Genome-scale metabolic modelling of SARS-CoV-2 in cancer cells reveals an increased shift to glycolytic energy production. FEBS Lett. 2021;595:2350\u201365. https:\/\/doi.org\/10.1002\/1873-3468.14180.","journal-title":"FEBS Lett"},{"key":"3538_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.106244","volume":"151","author":"G Magazz\u00f9","year":"2022","unstructured":"Magazz\u00f9 G, Zampieri G, Angione C. Clinical stratification improves the diagnostic accuracy of small omics datasets within machine learning and genome-scale metabolic modelling methods. Comput Biol Med. 2022;151:106244. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.106244.","journal-title":"Comput Biol Med"},{"issue":"21","key":"3538_CR26","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1093\/bioinformatics\/btz231","volume":"35","author":"LV Valc\u00e1rcel","year":"2019","unstructured":"Valc\u00e1rcel LV, Torrano V, Tobalina L, Carracedo A, Planes FJ. rMTA: robust metabolic transformation analysis. Bioinformatics. 2019;35(21):4350\u20135. https:\/\/doi.org\/10.1093\/bioinformatics\/btz231.","journal-title":"Bioinformatics"},{"issue":"23","key":"3538_CR27","doi-asserted-by":"publisher","first-page":"15112","DOI":"10.1073\/pnas.232349399","volume":"99","author":"D Segr\u00e8","year":"2002","unstructured":"Segr\u00e8 D, Vitkup D, Church GM. Analysis of optimality in natural and perturbed metabolic networks. Proc Natl Acad Sci U S A. 2002;99(23):15112\u20137. https:\/\/doi.org\/10.1073\/pnas.232349399.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3538_CR28","doi-asserted-by":"publisher","unstructured":"Orozco Rodriguez JM, Krupinska E, Wacklin-Knecht H, Knecht W. Protein production, kinetic and biophysical characterization of three human dihydroorotate dehydrogenase mutants associated with Miller syndrome. In: Nucleosides, Nucleotides & Nucleic Acids. Taylor & Francis; 2022. p. 1318\u201336. Available from: https:\/\/doi.org\/10.1080\/15257770.2021.2023749","DOI":"10.1080\/15257770.2021.2023749"},{"issue":"10\u201312","key":"3538_CR29","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1080\/15257770.2019.1708100","volume":"39","author":"JMO Rodriguez","year":"2020","unstructured":"Rodriguez JMO, Krupinska E, Wacklin-Knecht H, Knecht W. Preparation of human dihydroorotate dehydrogenase for interaction studies with lipid bilayers. Nucleosides Nucleotides Nucleic Acids. 2020;39(10\u201312):1306\u201319. https:\/\/doi.org\/10.1080\/15257770.2019.1708100.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"3538_CR30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI145660","author":"J Shintaku","year":"2022","unstructured":"Shintaku J, Pernice WM, Eyaid W, Gc JB, Brown ZP, Juanola-Falgarona M, et al. RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI145660.","journal-title":"J Clin Invest"},{"key":"3538_CR31","doi-asserted-by":"publisher","unstructured":"Pesta D, Gnaiger E. High-Resolution Respirometry: OXPHOS Protocols for Human Cells and Permeabilized Fibers from Small Biopsies of Human Muscle BT-Mitochondrial Bioenergetics: Methods and Protocols. In: Palmeira CM, Moreno AJ, editors. Totowa, NJ: Humana Press; 2012. p. 25\u201358. Available from: https:\/\/doi.org\/10.1007\/978-1-61779-382-0_3","DOI":"10.1007\/978-1-61779-382-0_3"},{"key":"3538_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109687","author":"L Baro","year":"2024","unstructured":"Baro L, Almhassneh RA, Islam A, Juanes MA. Tumor invasiveness is regulated by the concerted function of APC, formins, and Arp2\/3 complex. iScience. 2024. https:\/\/doi.org\/10.1016\/j.isci.2024.109687.","journal-title":"iScience"},{"issue":"6","key":"3538_CR33","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202001064","volume":"219","author":"SJ Lord","year":"2020","unstructured":"Lord SJ, Velle KB, Mullins RD, Fritz-Laylin LK. Superplots: communicating reproducibility and variability in cell biology. J Cell Biol. 2020;219(6):e202001064. https:\/\/doi.org\/10.1083\/jcb.202001064.","journal-title":"J Cell Biol"},{"issue":"15","key":"3538_CR34","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1091\/mbc.E21-03-0130","volume":"32","author":"M Kenny","year":"2021","unstructured":"Kenny M, Schoen I. Violin superplots: visualizing replicate heterogeneity in large data sets. Mol Biol Cell. 2021;32(15):1333\u20134. https:\/\/doi.org\/10.1091\/mbc.E21-03-0130.","journal-title":"Mol Biol Cell"},{"key":"3538_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112502","volume":"202","author":"S Yuan","year":"2020","unstructured":"Yuan S, Gopal JV, Ren S, Chen L, Liu L, Gao Z. Anticancer fungal natural products: mechanisms of action and biosynthesis. Eur J Med Chem. 2020;202:112502. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112502.","journal-title":"Eur J Med Chem"},{"issue":"4","key":"3538_CR36","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1110\/ps.03533004","volume":"13","author":"M Hansen","year":"2004","unstructured":"Hansen M, Le Nours J, Johansson E, Antal T, Ullrich A, L\u00f6ffler M, et al. Inhibitor binding in a class 2 dihydroorotate dehydrogenase causes variations in the membrane-associated N-terminal domain. Protein Sci. 2004;13(4):1031\u201342. https:\/\/doi.org\/10.1110\/ps.03533004.","journal-title":"Protein Sci"},{"key":"3538_CR37","doi-asserted-by":"publisher","unstructured":"Robert A. Copeland. Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis. Second. Enzymes. Wiley\u2010VCH; 2000. 1\u2013390 p. Available from: https:\/\/doi.org\/10.1002\/0471220639","DOI":"10.1002\/0471220639"},{"issue":"9","key":"3538_CR38","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0006-2952(98)00145-2","volume":"56","author":"W Knecht","year":"1998","unstructured":"Knecht W, L\u00f6ffler M. Species-related inhibition of human and rat dihydroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives. Biochem Pharmacol. 1998;56(9):1259\u201364. https:\/\/doi.org\/10.1016\/S0006-2952(98)00145-2.","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"3538_CR39","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1080\/15257770.2022.2039393","volume":"41","author":"JM Orozco Rodriguez","year":"2022","unstructured":"Orozco Rodriguez JM, Wacklin-Knecht H, Knecht W. Protein-lipid interactions of human dihydroorotate dehydrogenase and three mutants associated with Miller syndrome. Nucleosides Nucleotides Nucleic Acids. 2022;41(12):1337\u201358. https:\/\/doi.org\/10.1080\/15257770.2022.2039393.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"9","key":"3538_CR40","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0965-1748(02)00052-8","volume":"32","author":"M L\u00f6ffler","year":"2002","unstructured":"L\u00f6ffler M, Knecht W, Rawls J, Ullrich A, Dietz C. Drosophila melanogaster dihydroorotate dehydrogenase: the N-terminus is important for biological function in vivo but not for catalytic properties in vitro. Insect Biochem Mol Biol. 2002;32(9):1159\u201369. https:\/\/doi.org\/10.1016\/S0965-1748(02)00052-8.","journal-title":"Insect Biochem Mol Biol"},{"issue":"9","key":"3538_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04120-w","volume":"12","author":"Y Yu","year":"2021","unstructured":"Yu Y, Ding J, Zhu S, Alptekin A, Dong Z, Yan C, et al. Therapeutic targeting of both dihydroorotate dehydrogenase and nucleoside transport in MYCN-amplified neuroblastoma. Cell Death Dis. 2021;12(9):821. https:\/\/doi.org\/10.1038\/s41419-021-04120-w.","journal-title":"Cell Death Dis"},{"key":"3538_CR42","doi-asserted-by":"publisher","unstructured":"Talib WH, Alsayed AR, Barakat M, Abu-Taha MI, Mahmod AI. Targeting Drug Chemo-Resistance in Cancer Using Natural Products. Biomedicines. 2023;9(10):1353. Available from: https:\/\/doi.org\/10.3390\/biomedicines9101353","DOI":"10.3390\/biomedicines9101353"},{"issue":"7","key":"3538_CR43","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/s12276-024-01272-5","volume":"56","author":"L Thorel","year":"2024","unstructured":"Thorel L, Perr\u00e9ard M, Florent R, Divoux J, Coffy S, Vincent A, et al. Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology. Exp Mol Med. 2024;56(7):1531\u201351. https:\/\/doi.org\/10.1038\/s12276-024-01272-5.","journal-title":"Exp Mol Med"},{"key":"3538_CR44","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11570","author":"F Luo","year":"2016","unstructured":"Luo F, Li J, Wu S, Wu X, Chen M, Zhong X, et al. Comparative profiling between primary colorectal carcinomas and metastases identifies heterogeneity on drug resistance. Oncotarget. 2016. https:\/\/doi.org\/10.18632\/oncotarget.11570.","journal-title":"Oncotarget"},{"key":"3538_CR45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pharmthera.2018.10.012","volume":"195","author":"JT Madak","year":"2019","unstructured":"Madak JT, Bankhead A, Cuthbertson CR, Showalter HD, Neamati N. Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer. Pharmacol Ther. 2019;195:111\u201331. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.10.012.","journal-title":"Pharmacol Ther"},{"key":"3538_CR46","doi-asserted-by":"publisher","unstructured":"Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593(7860):586\u201390. Available from: https:\/\/doi.org\/10.1038\/s41586-021-03539-7","DOI":"10.1038\/s41586-021-03539-7"},{"key":"3538_CR47","doi-asserted-by":"publisher","unstructured":"Fuchs J, Cheblal A, Gasser SM. Underappreciated Roles of DNA Polymerase &#x3b4; in Replication Stress Survival. Trends Genet. 2021;37(5):476\u201387. Available from: https:\/\/doi.org\/10.1016\/j.tig.2020.12.003","DOI":"10.1016\/j.tig.2020.12.003"},{"key":"3538_CR48","doi-asserted-by":"publisher","unstructured":"Givechian KB, Garner C, Garban H, Rabizadeh S, Soon-Shiong P. CAD\/POLD2 gene expression is associated with poor overall survival and chemoresistance in bladder urothelial carcinoma. Oncotarget 2018;9;51; Available from: https:\/\/doi.org\/10.18632\/oncotarget.25701","DOI":"10.18632\/oncotarget.25701"},{"issue":"1","key":"3538_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S, Shen J, Jiang J, Wang F, Min J. Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther. 2023;8(1):372. https:\/\/doi.org\/10.1038\/s41392-023-01606-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"3538_CR50","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"issue":"6690","key":"3538_CR51","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1126\/science.adh2771","volume":"383","author":"U Sahu","year":"2024","unstructured":"Sahu U, Villa E, Reczek CR, Zhao Z, O\u2019Hara BP, Torno MD, et al. Pyrimidines maintain mitochondrial pyruvate oxidation to support de novo lipogenesis. Science. 2024;383(6690):1484\u201392. https:\/\/doi.org\/10.1126\/science.adh2771.","journal-title":"Science"},{"key":"3538_CR52","doi-asserted-by":"publisher","unstructured":"Koundinya M, Sudhalter J, Courjaud A, Lionne B, Touyer G, Bonnet L, et al. Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a Synthetic Lethal Vulnerability in Mutant KRAS-Driven Cancers. Cell Chem Biol. 2018;25(6):705\u2013717.e11. Available from: https:\/\/doi.org\/10.1016\/j.chembiol.2018.03.005","DOI":"10.1016\/j.chembiol.2018.03.005"},{"key":"3538_CR53","doi-asserted-by":"publisher","unstructured":"Teodoro JS, Palmeira CM, Rolo AP. Mitochondrial Membrane Potential (\u0394\u03a8) Fluctuations Associated with the Metabolic States of Mitochondria BT - Mitochondrial Bioenergetics: Methods and Protocols. In: Palmeira CM, Moreno AJ, editors. New York, NY: Springer New York; 2018. p. 109\u201319. Available from: https:\/\/doi.org\/10.1007\/978-1-4939-7831-1_6","DOI":"10.1007\/978-1-4939-7831-1_6"},{"issue":"1","key":"3538_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/mog2.6","volume":"1","author":"X Yang","year":"2022","unstructured":"Yang X, Li C, Gou K, Liu X, Zhou Y, Zou J, et al. A novel and potent dihydroorotate dehydrogenase inhibitor suppresses the proliferation of colorectal cancer by inducing mitochondrial dysfunction and DNA damage. MedComm \u2013 Oncology. 2022;1(1):e6. https:\/\/doi.org\/10.1002\/mog2.6.","journal-title":"MedComm \u2013 Oncology"},{"issue":"2","key":"3538_CR55","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20120097","volume":"33","author":"J Fang","year":"2013","unstructured":"Fang J, Uchiumi T, Yagi M, Matsumoto S, Amamoto R, Takazaki S, et al. Dihydro-orotate dehydrogenase is physically associated with the respiratory complex and its loss leads to mitochondrial dysfunction. Biosci Rep. 2013;33(2):e00021. https:\/\/doi.org\/10.1042\/BSR20120097.","journal-title":"Biosci Rep"},{"issue":"3","key":"3538_CR56","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1567-7249(02)00045-4","volume":"2","author":"JH Spodnik","year":"2002","unstructured":"Spodnik JH, Wozniak M, Budzko D, Teranishi M, Karbowski M, Nishizawa Y, et al. Mechanism of leflunomide-induced proliferation of mitochondria in mammalian cells. Mitochondrion. 2002;2(3):163\u201379. https:\/\/doi.org\/10.1016\/S1567-7249(02)00045-4.","journal-title":"Mitochondrion"},{"key":"3538_CR57","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.biochi.2017.02.003","volume":"135","author":"AK Mohamad Fairus","year":"2017","unstructured":"Mohamad Fairus AK, Choudhary B, Hosahalli S, Kavitha N, Shatrah O. Dihydroorotate dehydrogenase (DHODH) inhibitors affect ATP depletion, endogenous ROS and mediate S-phase arrest in breast cancer cells. Biochimie. 2017;135:154\u201363. https:\/\/doi.org\/10.1016\/j.biochi.2017.02.003.","journal-title":"Biochimie"},{"issue":"6","key":"3538_CR58","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1593\/neo.10168","volume":"12","author":"N Hail","year":"2010","unstructured":"Hail N, Chen P, Bushman LR. Teriflunomide (Leflunomide) promotes cytostatic, antioxidant, and apoptotic effects in transformed prostate epithelial cells: evidence supporting a role for teriflunomide in prostate cancer chemoprevention. Neoplasia. 2010;12(6):464\u201375. https:\/\/doi.org\/10.1593\/neo.10168.","journal-title":"Neoplasia"},{"issue":"22","key":"3538_CR59","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.1111\/febs.16164","volume":"289","author":"R Banerjee","year":"2022","unstructured":"Banerjee R, Purhonen J, Kallij\u00e4rvi J. The mitochondrial coenzyme Q junction and complex III: biochemistry and pathophysiology. FEBS J. 2022;289(22):6936\u201358. https:\/\/doi.org\/10.1111\/febs.16164.","journal-title":"FEBS J"},{"key":"3538_CR60","doi-asserted-by":"publisher","unstructured":"Bajzikova M, Kovarova J, Coelho AR, Boukalova S, Oh S, Rohlenova K, et al. Reactivation of Dihydroorotate Dehydrogenase-Driven Pyrimidine Biosynthesis Restores Tumor Growth of Respiration-Deficient Cancer Cells. Cell Metab. 2019;29(2):399\u2013416.e10. Available from: https:\/\/doi.org\/10.1016\/j.cmet.2018.10.014","DOI":"10.1016\/j.cmet.2018.10.014"},{"issue":"6","key":"3538_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165759","volume":"1866","author":"S Boukalova","year":"2020","unstructured":"Boukalova S, Hubackova S, Milosevic M, Ezrova Z, Neuzil J, Rohlena J. Dihydroorotate dehydrogenase in oxidative phosphorylation and cancer. Biochimica et Biophysica Acta (BBA). 2020;1866(6):165759. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165759.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"8","key":"3538_CR62","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.050775","volume":"17","author":"M Yag\u00fce-Capilla","year":"2024","unstructured":"Yag\u00fce-Capilla M, Rudd SG. Understanding the interplay between dNTP metabolism and genome stability in cancer. Dis Model Mech. 2024;17(8):dmm050775. https:\/\/doi.org\/10.1242\/dmm.050775.","journal-title":"Dis Model Mech"},{"issue":"2","key":"3538_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2224-7","volume":"11","author":"S Hubackova","year":"2020","unstructured":"Hubackova S, Davidova E, Boukalova S, Kovarova J, Bajzikova M, Coelho A, et al. Replication and ribosomal stress induced by targeting pyrimidine synthesis and cellular checkpoints suppress p53-deficient tumors. Cell Death Dis. 2020;11(2):110. https:\/\/doi.org\/10.1038\/s41419-020-2224-7.","journal-title":"Cell Death Dis"},{"issue":"4","key":"3538_CR64","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1158\/2159-8290.CD-16-0612","volume":"7","author":"D Mathur","year":"2017","unstructured":"Mathur D, Stratikopoulos E, Ozturk S, Steinbach N, Pegno S, Schoenfeld S, et al. Pten regulates glutamine flux to pyrimidine synthesis and sensitivity to dihydroorotate dehydrogenase inhibition. Cancer Discov. 2017;7(4):380\u201390. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0612.","journal-title":"Cancer Discov"},{"issue":"27","key":"3538_CR65","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1038\/onc.2013.313","volume":"33","author":"T He","year":"2014","unstructured":"He T, Haapa-Paananen S, Kaminskyy VO, Kohonen P, Fey V, Zhivotovsky B, et al. Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis. Oncogene. 2014;33(27):3538\u201349. https:\/\/doi.org\/10.1038\/onc.2013.313.","journal-title":"Oncogene"},{"issue":"24","key":"3538_CR66","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00328-17","volume":"37","author":"M Eriksson","year":"2017","unstructured":"Eriksson M, Ambroise G, Ouchida AT, Lima Queiroz A, Smith D, Gimenez-Cassina A, et al. Effect of mutant p53 proteins on glycolysis and mitochondrial metabolism. Mol Cell Biol. 2017;37(24):e00328\u201317. https:\/\/doi.org\/10.1128\/MCB.00328-17.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"3538_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101245","volume":"12","author":"R Shi","year":"2025","unstructured":"Shi R, Cheng Y, Wang J, Song N, Chen Y, Teng Z, et al. Genetic feature diversity of KRAS-mutated colorectal cancer and the negative association of DNA mismatch repair deficiency relevant mutational signatures with prognosis. Genes Dis. 2025;12(1):101245. https:\/\/doi.org\/10.1016\/j.gendis.2024.101245.","journal-title":"Genes Dis"},{"key":"3538_CR68","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.freeradbiomed.2014.04.007","volume":"72","author":"M Hey-Mogensen","year":"2014","unstructured":"Hey-Mogensen M, Goncalves RLS, Orr AL, Brand MD. Production of superoxide\/H2O2 by dihydroorotate dehydrogenase in rat skeletal muscle mitochondria. Free Radic Biol Med. 2014;72:149\u201355. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.04.007.","journal-title":"Free Radic Biol Med"},{"key":"3538_CR69","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tox.2017.10.002","volume":"392","author":"Z Ren","year":"2017","unstructured":"Ren Z, Chen S, Qing T, Xuan J, Couch L, Yu D, et al. Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 cells. Toxicology. 2017;392:11\u201321. https:\/\/doi.org\/10.1016\/j.tox.2017.10.002.","journal-title":"Toxicology"},{"key":"3538_CR70","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tox.2018.02.003","volume":"396","author":"J Xuan","year":"2018","unstructured":"Xuan J, Ren Z, Qing T, Couch L, Shi L, Tolleson WH, et al. Mitochondrial dysfunction induced by leflunomide and its active metabolite. Toxicology. 2018;396:33\u201345. https:\/\/doi.org\/10.1016\/j.tox.2018.02.003.","journal-title":"Toxicology"},{"issue":"19","key":"3538_CR71","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.1021\/bi7001554","volume":"46","author":"AE Wolfe","year":"2007","unstructured":"Wolfe AE, Thymark M, Gattis SG, Fagan RL, Hu Y, Johansson E, et al. Interaction of benzoate pyrimidine analogues with class 1A dihydroorotate dehydrogenase from Lactococcus lactis. Biochemistry. 2007;46(19):5741\u201353. https:\/\/doi.org\/10.1021\/bi7001554.","journal-title":"Biochemistry"},{"key":"3538_CR72","doi-asserted-by":"publisher","unstructured":"DeFrees SA, Sawick DP, Cunningham B, Heinstein PF, James Morr\u00e9 D, Cassady JM. Structure-activity relationships of pyrimidines as dihydroorotate dehydrogenase inhibitors. Biochem Pharmacol. 1988;37(20):3807\u201316. Available from: https:\/\/doi.org\/10.1016\/0006-2952(88)90060-3","DOI":"10.1016\/0006-2952(88)90060-3"},{"key":"3538_CR73","doi-asserted-by":"publisher","unstructured":"Munier-Lehmann H, Vidalain P-O, Tangy F, Janin YL. On Dihydroorotate Dehydrogenases and Their Inhibitors and Uses. J Med Chem. 2013;56(8):3148\u201367. Available from: https:\/\/doi.org\/10.1021\/jm301848w","DOI":"10.1021\/jm301848w"},{"key":"3538_CR74","unstructured":"Knecht W. (1998) Expression, Charakterisierung und Untersuchung zur Inhibition der DihydroorotatDehydrogenase des Menschen und der Ratte. Dissertation, Philipps-Universit\u00e4t Marburg, Fachbereich Medizin"},{"issue":"7527","key":"3538_CR75","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13909","volume":"515","author":"ET Chouchani","year":"2014","unstructured":"Chouchani ET, Pell VR, Gaude E, Aksentijevi\u0107 D, Sundier SY, Robb EL, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515(7527):431\u20135. https:\/\/doi.org\/10.1038\/nature13909.","journal-title":"Nature"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03538-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03538-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03538-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:52:24Z","timestamp":1760705544000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03538-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3538"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03538-w","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human colorectal healthy and tumor tissue samples were obtained from the NHS Queen\u2019s Medical Centre Hospital, Nottingham, UK, under the ethical approval number 17\/EM\/0126. All participants provided written informed consent prior to sample collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"292"}}